Feeding and Transition to Home for Preterms at Social Risk (H-HOPE)
Premature Birth
About this trial
This is an interventional treatment trial for Premature Birth focused on measuring preterm infant, stable infant, mother-infant interaction, health care cost, H-HOPE intervention, mother outcomes, infant behavioral organization, infant growth
Eligibility Criteria
Inclusion Criteria:
29-34 weeks gestation at birth
no other major health problems
mothers have at least 2 socio-environmental risk factors such as African American or Latina
Less then high school education
history of mental illness
less than 150% poverty level
2 children less than 24 months old
4 or more children living in the home
living in a disadvantaged neighborhood
Exclusion Criteria:
Infant has congenital anomaly
Necrotizing enterocolitis
Brain injury
chronic lung disease
prenatal drug exposure
mother is an illicit drug user
mother is not the legal guardian
-
Sites / Locations
- Mercy Hospital and Medical Center
- Mount Sinai Medical Center
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Attention Control
H-HOPE Intervention
Mothers received equal amount of attention from the team. Attention consisted of additional teaching regarding premature infant care.
H-HOPE was administered twice daily by the mother.